AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29464110
Drug: Study drugs
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Study drugs
Trial: 17928878
Drug: Irbesartan/HCTZ combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan/HCTZ combination therapy (300 mg/25 mg)
Trial: 17928878
Drug: Irbesartan monotherapy
RxNorm normalized name: Irbesartan
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Irbesartan monotherapy (300 mg)
Trial: 17928878
Drug: HCTZ monotherapy
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HCTZ monotherapy (25 mg)
Trial: 11707864
Drug: Bexarotene gel
RxNorm normalized name: Bexarotene
DrugBank: Bexarotene (DB00307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Bexarotene gel applied to target lesions
Trial: 11707864
Drug: High-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose oral bexarotene (300 mg/m²)
Trial: 11707864
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral bexarotene (6.5 mg/m²)
Trial: 11707864
Drug: High-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose oral bexarotene (300 mg/m²) for erythrodermic CTCL
Trial: 11707864
Drug: Atorvastatin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (60 mg/day)
Trial: 8806288
Drug: Recombinant hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hepatitis B vaccine (comparator)
Trial: 1321006
Drug: Six-drug alternating
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Six-drug alternating combination treatment
Trial: 1321006
Drug: Three-drug 'standard'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-drug 'standard' combination treatment
Trial: 30902791
Drug: Calcium and
RxNorm normalized name: Calcium and Magnesium
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium and vitamin D fortified snack bars (2000 mg Ca and 1000 IU vitamin D per day)
Trial: 29803270
Drug: ASA24 (Automated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA24 (Automated Self-Administered 24-Hour Dietary Assessment Tool)
Trial: 29803270
Drug: AMPM (Interview-Administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMPM (Interview-Administered Automated Multiple Pass Method)
Trial: 10992842
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion (75‐150 micrograms kg‐1 min‐1)
Trial: 8854471
Drug: Pulsed therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed therapy with oral dexamethasone, 40 mg/day on 4 consecutive days each month for 6 months
Trial: 8854471
Drug: Dexamethasone tablets
RxNorm normalized name: Dexamethasone Tablets
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone tablets
Trial: 6515368
Drug: pirbuterol 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pirbuterol 0.4 mg
Trial: 31590640
Drug: Active program
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active program of knowledge transfer about WHO recommendations for preeclampsia, including antenatal corticosteroids, antihypertensive therapy, and magnesium sulphate for seizure prophylaxis.
Trial: 28731266
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) 1,000 mg/day
Trial: 23921600
Drug: Close monitoring
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Close monitoring of cerebral rStO2 and a treatment guideline to correct deviations in rStO2
Trial: 23921600
Drug: Treatment guideline
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment guideline
Trial: 10397375
Drug: Sparfloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sparfloxacin (400 mg loading dose followed by 200 mg once daily for up to 10 days)
Trial: 6419519
Drug: Piribedil 40
RxNorm normalized name: piribedil
DrugBank: Piribedil (DB12478)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piribedil 40 mg
Trial: 6419519
Drug: Piribedil 60
RxNorm normalized name: piribedil
DrugBank: Piribedil (DB12478)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piribedil 60 mg
Trial: 6419519
Drug: Piribedil 100
RxNorm normalized name: piribedil
DrugBank: Piribedil (DB12478)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piribedil 100 mg
Trial: 6419519
Drug: Piribedil (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piribedil (all doses)
Trial: 31093929
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin 338 administered 0 min before meal
Trial: 31093929
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin 338 administered 30 min before meal
Trial: 31093929
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin 338 administered 60 min before meal
Trial: 31093929
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin 338 administered 360 min before meal
Trial: 29772035
Drug: MDI implants
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI implants (3M ESPE)
Trial: 29772035
Drug: SlimLine implants
RxNorm normalized name: benzalkonium chloride Topical Foam [DigiClean Slim-Line]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SlimLine implants (Dentium)
Trial: 10320236
Drug: Aortic homograft
RxNorm normalized name: chloroxylenol / hydrocortisone / pramoxine hydrochloride Otic Solution [Cortic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aortic homograft preserved in antibiotic solution at 4 degrees C
Trial: 8708151
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of intralesional IFN alfa-2a and 2b
Trial: 19161542
Drug: 2000 IU
RxNorm normalized name: D 2000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 IU daily of vitamin D(2) for mothers
Trial: 19161542
Drug: 60,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60,000 IU monthly of vitamin D(2) for mothers
Trial: 19161542
Drug: 400 IU
RxNorm normalized name: Vitamin D 400 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 IU daily of vitamin D(2) for infants
Trial: 17450047
Drug: Fast/once daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast/once daily titration (1.2 mg/kg/day over 3 days)
Trial: 17450047
Drug: Slow/twice daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow/twice daily titration (1.2 mg/kg/day over at least 2 weeks)
Trial: 17450047
Drug: Slow/twice daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow/twice daily titration
Trial: 15016780
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist therapy with 400 mcg buserelin acetate daily followed by 6 mg of oral estradiol valerate starting on menstrual day 1
Trial: 15016780
Drug: No GnRH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No GnRH agonist therapy, starting 6 mg of oral estradiol valerate on day 1 of bleeding
Trial: 11206232
Drug: Formoterol 12
RxNorm normalized name: formoterol 12 mcg inhalation capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 12 microg twice daily
Trial: 11206232
Drug: Formoterol (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol (both doses)
Trial: 9537731
Drug: Gauze drain
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gauze drain impregnated with chlortetracycline ointment
Trial: 9537731
Drug: No drain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drain treatment (control)
Trial: 8079448
Drug: Low-dose IVIgG
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose IVIgG (85.7 +/- 11.6 mg/kg by ultrasound‐estimated fetal weight)
Trial: 8079448
Drug: Low-dose IVIgG
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose IVIgG
Trial: 2590616
Drug: Intranasal metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal metoclopramide (5 mg in 0.5 ml sterile water)
Trial: 2590616
Drug: Oral route
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral route (implied control)
Trial: 241307
Drug: Single daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single daily administration of phenothiazine medication
Trial: 241307
Drug: Multiple administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple administration schedule of phenothiazine medication
Trial: 31329855
Drug: AKCEA-APOCIII-LRx 10
RxNorm normalized name: AKCEA-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AKCEA-APOCIII-LRx 10 mg
Trial: 31329855
Drug: AKCEA-APOCIII-LRx 30
RxNorm normalized name: AKCEA-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AKCEA-APOCIII-LRx 30 mg
Trial: 31329855
Drug: AKCEA-APOCIII-LRx 60
RxNorm normalized name: AKCEA-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AKCEA-APOCIII-LRx 60 mg
Trial: 31329855
Drug: AKCEA-APOCIII-LRx 90
RxNorm normalized name: AKCEA-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AKCEA-APOCIII-LRx 90 mg
Trial: 31329855
Drug: AKCEA-APOCIII-LRx 120
RxNorm normalized name: AKCEA-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AKCEA-APOCIII-LRx 120 mg
Trial: 31329855
Drug: AKCEA-APOCIII-LRx 15
RxNorm normalized name: AKCEA-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AKCEA-APOCIII-LRx 15 mg weekly for 6 weeks
Trial: 31329855
Drug: AKCEA-APOCIII-LRx 30
RxNorm normalized name: AKCEA-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AKCEA-APOCIII-LRx 30 mg weekly for 6 weeks
Trial: 31329855
Drug: AKCEA-APOCIII-LRx 60
RxNorm normalized name: AKCEA-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AKCEA-APOCIII-LRx 60 mg every 4 weeks for 3 months
Trial: 21159452
Drug: MMT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMT with weekly individual BDRC (n=20)
Trial: 16640847
Drug: DTPw-HB/Hib vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPw-HB/Hib vaccine (5 microg of PRP), given as a single injection
Trial: 16640847
Drug: Licensed DTPw-HB
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Licensed DTPw-HB (Tritanrix) and Hib (Hiberix) vaccines, given as simultaneous concomitant injections
Trial: 16640847
Drug: DTPw-HB/Hib vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPw-HB/Hib vaccine
Trial: 16640847
Drug: Licensed DTPw-HB
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Licensed DTPw-HB and Hib vaccines
Trial: 12969103
Drug: Intrathecal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal midazolam (1 mg) added to 3 ml of 0.5% hyperbaric bupivacaine
Trial: 12969103
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (3 ml of 0.5% hyperbaric bupivacaine alone
Trial: 29077615
Drug: Epinephrine 200
RxNorm normalized name: Cocaine (as cocaine hydrochloride) 50 mg/mL and epinephrine 200 microgram/mL eye solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine 200 µg (high-dose group)
Trial: 29077615
Drug: Epinephrine 100
RxNorm normalized name: Epinephrine 100 microgram/mL solution for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine 100 µg (low-dose group)
Trial: 27837602
Drug: Multicomponent behavioral
RxNorm normalized name: meningococcus B, multicomponent vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multicomponent behavioral intervention administered by lay health workers (5 weekly 90-minute sessions)
Trial: 20486914
Drug: Dual immunosuppressive
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual immunosuppressive therapy
Trial: 20486914
Drug: Lower blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower blood concentrations of calcineurin inhibitors
Trial: 20486914
Drug: Valganciclovir/ganciclovir therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valganciclovir/ganciclovir therapy with lower total intensity of immunosuppressive therapy
Trial: 20486914
Drug: Mycophenolate and
RxNorm normalized name: mycophenolate
DrugBank: Mycophenolic acid (DB01024)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mycophenolate and tacrolimus therapy
Trial: 11916787
Drug: Placebo (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (same formulation without lidocaine) via iontophoresis
Trial: 10216810
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg once daily for 10 weeks
Trial: 10216810
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg once daily for 2 weeks, with the option to increase to 10 mg once daily if diastolic blood pressure exceeded 90 mmHg
Trial: 2223679
Drug: Betamethasone (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone (1.5 mg orally per day from day 259 to day 273, then 1 mg until delivery)
Trial: 30608872
Drug: Echinacea purpurea
RxNorm normalized name: Echinacea purpurea
DrugBank: Echinacea purpurea (DB14239)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Echinacea purpurea (8000 mg·day‐1)
Trial: 29285889
Drug: Topical liposome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical liposome incorporated clove oil 45%
Trial: 29285889
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline solution (control)
Trial: 22169248
Drug: Davunetide (AL-108)
RxNorm normalized name: Al
DrugBank: Davunetide (DB12613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Davunetide (AL-108) 5 mg
Trial: 22169248
Drug: Davunetide (AL-108)
RxNorm normalized name: Al
DrugBank: Davunetide (DB12613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Davunetide (AL-108) 30 mg
Trial: 11889309
Drug: Inspired gas
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspired gas conditions of 30 degrees C, 30 mg/L; 34 degrees C, 38 mg/L; 37 degrees C, 44 mg/L; and 40 degrees C, 50 mg/L
Trial: 10080336
Drug: IFN-alpha (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN-alpha (1 x 10(6) IU per dose)
Trial: 10080336
Drug: 5-FU (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-FU (5 mg per dose)
Trial: 22322513
Drug: Scaling, root
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling, root planning, and systemic administration of doxycycline
Trial: 19804842
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy (PPI, amoxicillin followed by PPI, clarithromycin, and imidazole agent)
Trial: 19804842
Drug: Concomitant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant therapy (PPI, amoxicillin, clarithromycin, and imidazole agent)
Trial: 17626987
Drug: Crystacide (hydrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crystacide (hydrogen peroxide cream) applied onto the skin for 10 days
Trial: 12395437
Drug: Renal protection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renal protection with mannitol (0.3 g/kg) before aortic cross-clamping (ACC) and furosemide (20-40 mg) or dopamine (1-3 micrograms/kg/min) until the end of surgery.
Trial: 10091344
Drug: Topical ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical ciprofloxacin (0.2%)
Trial: 10091344
Drug: Oral ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ciprofloxacin (500 mg/12 h)
Trial: 10091344
Drug: Oral ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ciprofloxacin plus 0.2% topical solution
Trial: 10091344
Drug: Topical polymyxin
RxNorm normalized name: polymyxin B Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical polymyxin and neomycin
Trial: 7748985
Drug: Loxiglumide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loxiglumide (10 mg/kg ideal weight/h)
Trial: 2148224
Drug: isradipine 1
RxNorm normalized name: isradipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: isradipine 1 mg i.v. (5 min)
Trial: 2148224
Drug: isradipine 5
RxNorm normalized name: isradipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: isradipine 5 mg solution
Trial: 2148224
Drug: isradipine 5
RxNorm normalized name: isradipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: isradipine 5 mg tablet
Trial: 2148224
Drug: isradipine 10
RxNorm normalized name: isradipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: isradipine 10 mg sustained release
Trial: 26022239
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no high-dose cytarabine)
Trial: 21222604
Drug: EHT0202 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EHT0202 (40 or 80 mg bid)
Trial: 19573497
Drug: Dextroamphetamine 30
RxNorm normalized name: dextroamphetamine 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine 30 mg/d
Trial: 19573497
Drug: Caffeine 300
RxNorm normalized name: caffeine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 300 mg/d
Trial: 9398875
Drug: Lansoprazole, 30
RxNorm normalized name: Lansoprazole, 30 mg oral tablet, disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole, 30 mg bid plus amoxicillin, 1 gm tid
Trial: 9398875
Drug: Lansoprazole, 30
RxNorm normalized name: Lansoprazole, 30 mg oral tablet, disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole, 30 mg tid plus amoxicillin, 1 gm tid
Trial: 9398875
Drug: Lansoprazole, 30
RxNorm normalized name: Lansoprazole, 30 mg oral tablet, disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole, 30 mg tid alone
Trial: 9398875
Drug: Amoxicillin, 1
RxNorm normalized name: Amoxicillin, 125 mg oral tablet, chewable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin, 1 gm tid alone
Trial: 9398875
Drug: Lansoprazole, 30
RxNorm normalized name: Lansoprazole, 30 mg oral tablet, disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole, 30 mg bid plus amoxicillin
Trial: 9398875
Drug: Lansoprazole, 30
RxNorm normalized name: Lansoprazole, 30 mg oral tablet, disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole, 30 mg tid plus amoxicillin
Trial: 1572111
Drug: Probenecid (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probenecid (1000 mg/d)
Trial: 1572111
Drug: Probenecid (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probenecid (2000 mg/d)
Trial: 1572111
Drug: Furosemide (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (0.5 mg/kg intravenously)
Trial: 4048886
Drug: Adenosine infusion
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine infusion (0.1 mg/kg/min)
Trial: 28207540
Drug: 3.75 mg
RxNorm normalized name: zopiclone 3.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg enantone
Trial: 21730029
Drug: Postexercise protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postexercise protein feeding (PTN: 0.4, 1.2, 0.2 g/kg protein, carbohydrate, and fat respectively)
Trial: 21730029
Drug: Isocaloric carbohydrate
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isocaloric carbohydrate and fat (CON: 1.6, 0.2 g/kg)
Trial: 30102667
Drug: V-pattern injection
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: V-pattern injection (group 1)
Trial: 30102667
Drug: Middle horizontal
RxNorm normalized name: wheat middlings extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Middle horizontal pattern injection (group 2)
Trial: 30102667
Drug: High horizontal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High horizontal pattern injection (group 3)